Indications |
Oral Menorrhagia Adult: 10-15 mg daily in a cyclical regimen. Usual dose: 5 mg tid for 10 days as primary treatment, subsequently 5 mg bid on days 19-26 of cycle to prevent recurrence. As acetate: 2.5-10 mg daily in a cyclical regimen, beginning during the assumed latter half of the cycle. Oral Endometriosis Adult: 10-25 mg daily continuously for 4-9 mth. As acetate: 5-15 mg daily, start at 5 mg daily and increase by 2.5 mg at 14 day intervals. Take continuously for 4-9 mth. Oral Contraception Adult: 0.35 mg daily, or 0.5-1 mg daily when combined with oestrogen. As acetate: 0.6 mg daily, or 1-1.5 mg daily when combined with oestrogen. Oral Progestogen component of menopausal hormonal replacement therapy Adult: 0.7 mg as a continuous daily dose. As acetate: 1 mg daily for 10-12 days of a 28-day cycle. Oral Premenstrual syndrome Adult: 5 mg tid on days 16-25 of cycle. Oral Breast cancer Adult: 40 mg daily increasing to 60 mg daily if no regression is noted. Oral Postponement of menstruation Adult: 5 mg tid starting 3 days before expected onset of menstruation. Transdermal Progestogen component of menopausal hormonal replacement therapy Adult: As acetate: 140, 170 or 250 mcg/day (as patch), applied twice wkly for 2 wk of a 4 wk cycle. Lower strength may also be applied twice wkly on a continuous basis. Intramuscular Contraception Adult: As enantate: 200 mg every 8 wk. |
Contraindications |
Severe hepatic dysfunction; undiagnosed vaginal bleeding; porphyria; pregnancy; previous idiopathic or current thromboembolism; thromboembolic disease; DVT. |
Warnings / Precautions |
Hypertension; CVS disease; hepatic impairment; epilepsy; lactation; new onset of migraine-type headache; asthma; renal impairment; history of clinical depression. |
Adverse Reactions |
Mental depression, cholestatic jaundice, porphyria, epilepsy, migraine, headache, breast discomfort, dizziness, nausea and vomiting, changes in libido, appetite and weight, breakthrough bleeding, changes in menstrual flow, amenorrhoea, oedema, rash, melasma or cholasma, acne, urticaria, abnormal LFTs, moodswings, insomnia, thrombotic and thromoembolic events, optic neuritis, altered lipid profile. |
Overdose Reactions |
Symptoms include nausea, vomiting, breast enlargement, vaginal bleeding. Treatment should be symptomatic. |
Drug Interactions |
Concentration may be reduced by CYP450 inducers (e.g. phenobarbital, phenytoin, carbamazepine, rifampicin, rifabutin, nevirapine, efavirenz, tetracyclines, ampicillin, oxacillin, co-trimoxazole) and ritonavir, nelfinavir (usually inhibitors of CYP450 but have inducing properties when used with steroid hormones). May cause additive fluid retention with NSAIDs, vasodilators. Adjustment in antidiabetic, thyroid hormone and anticoagulant therapy may be required. Potentially Fatal: May increase ciclosporin concentration. See Below for More norethisterone Drug Interactions |
Lab Interactions |
Abnormal thyroid function tests, metyropone test and LFTs reported. |
Food Interactions |
St John's wort may induce norethisterone metabolism, leading to decreased concentrations. |
Mechanism of Actions |
Norethisterone has typical effects of a progestogen and converts the endometrium from the proliferative to the secretory phase. It may also have some oestrogenic, anabolic and androgenic activities, but these may not be significant. Norethisterone delays onset of periods and controls abnormal uterine bleeding. It also has contraceptive effects due to negative feedback inhibition of pituitary gonadotropin thus preventing ovulation. Absorption: Absorbed from the GI tract (oral). Distribution: Highly protein bound Metabolism: Hepatic; extensive first-pass effect. Excretion: Via urine (50-80%); via faeces (40%). |
Administration |
May be taken with or without food. |
Storage Conditions |
Oral: Store below 25°C. Transdermal: Store below 25°C. |
ATC Classification |
G03AC01 - norethisterone ; Belongs to the class of progestogens. Used as systemic contraceptives. G03DC02 - norethisterone ; Belongs to the class of estren derivative progestogens used in progestogenic hormone preparations. |
Storage |
Oral: Store below 25°C. Transdermal: Store below 25°C. |
Available As |
|
Norethisterone
One Response to Norethisterone
Post Review about Norethisterone Click here to cancel reply.
Norethisterone Containing Brands
Norethisterone is used in following diseases
Drug - Drug Interactions of Norethisterone
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
This is very good information. what is the cost of the drug?